glutathione and triple negative breast cancer depletion dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative Frontiers | Oxidative stress and
Frontiers Oxidative stress and antioxidants in breast cancer: a double edged sword The Potential of Hormonal Therapies for Treatment of Triple Negative Breast Cancer Ratiometrically designed nanoprodrug for triple negative breast cancer treatment Targeting the redox programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Cell Death Discovery glutathione and breast cancer Glutathione depleting self immolative nanoparticles boost cuproptosis driven metalloimmunotherapy for triple negative Journal of Nanobiotechnology A study shows that the Mitochondrial Redox Vulnerabilities in Triple Negative Breast Cancer: Integrative Perspectives and Emerging Therapeutic Strategies
Pay in 4 interest-free payments of $6.73 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12




